This compound is primarily utilized in the field of pharmaceutical research, particularly in the development of central nervous system (CNS) agents. Its structure suggests potential activity as a serotonin-norepinephrine reuptake inhibitor (SNRI), making it a candidate for studying treatments for depression, anxiety, and other mood disorders. Additionally, it may be explored for its effects on neurotransmitter regulation, which could contribute to advancements in understanding and managing neurological conditions. Researchers also investigate its potential use in creating enantiomerically pure drugs, as the (R)-enantiomer may exhibit distinct pharmacological properties compared to its (S)-counterpart.